Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Japan

Japan's Kyowa Hakko Invests In Antibodies

July 2006 | Company Finance Alert

Japanese pharmaceutical company Kyowa Hakko Kogyo is to invest some US$27mn on a new GMP-compliant animal cell culture unit. The expansion to the Fuji manufacturing facility is expected to begin in early 2007, with the site coming onstream in early 2009. Company sources note that the purpose of the expansion is to boost development activity on antibodies for use in clinical

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Novartis Plans OTC Market Assault

Companies / Japan Swiss drugmaker Novartis has launched its consumer healthcare division in Japan and it is planning to become a top 10 player within the next five years. Given the company's diversified portfolio of products...
January 2007
GSK To Boost Japan Launches

Companies / Japan According to international reports, UK drug major GlaxoSmithKline (GSK) is to increase launches of new products in Japan, aiming to boost sales by 10% per year. With local revenues of JPY186.6bn (US$1.62bn)...
June 2006
Amgen Boosts Japan Sales Force, Eyeing New Products

Companies / Japan Leading US biotech Amgen is to strengthen its Japanese sales force, with the aim of assuming full control of marketing efforts for new cancer drugs. The company currently outsources all marketing activity...
June 2006
Industry Slams Japan's Regulatory Reforms

Companies / Japan Stakeholders in Japan's drug industry have criticised the government's handling of its five-year industry plan. The strategy was first outlined in 2002, and a draft version of the new five-year plan...
June 2006
Sanofi-Aventis Pledges Japan Expansion

Companies / Japan French drug major Sanofi-Aventis is to expand in Japan and make the market a 'priority' over the next few years. The announcement follows the company's decision to reassume exclusive local rights to...
April 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS